Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$113,840,426
+$231,045 QoQ
Shares Held
452,394
-13.4% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#235
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ING GROEP NV holds $464,230,493 across 8 Drug Manufacturers - General names. ABBV ranks #2 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
104,043 | $124,792,305 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
452,394 | $113,840,426 | |
| 3 | MRK |
Merck & Co., Inc.
|
717,830 | $92,241,155 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
885,384 | $51,015,826 | |
| 5 | JNJ |
Johnson & Johnson
|
172,474 | $43,803,221 | |
| 6 | PFE |
Pfizer Inc
|
748,214 | $18,016,993 | |
| 7 | AMGN |
Amgen Inc
|
40,912 | $14,815,053 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
45,160 | $5,705,514 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $113,840,426 | 452,394 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $113,609,381 | 522,366 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $180,743,587 | 791,035 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $213,364,341 | 921,501 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $73,005,274 | 393,305 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $113,203,027 | 540,297 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $106,324,129 | 598,335 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $66,111,959 | 334,778 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $73,984,465 | 431,346 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $79,333,321 | 435,658 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $40,979,336 | 264,434 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $45,264,752 | 303,668 | Shares | Defined | 2023-10-27 | |
| 2023-06-30 | $56,077,455 | 416,221 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $102,194,737 | 641,242 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $65,732,120 | 406,733 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $59,769,484 | 445,343 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $60,691,181 | 396,260 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $45,463,263 | 280,447 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $31,133,469 | 229,937 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $24,101,501 | 223,431 | Shares | Defined | 2021-11-02 | |
| 2021-06-30 | $16,347,443 | 145,130 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $12,690,310 | 117,264 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $12,631,163 | 117,883 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $3,553,000 | 40,564 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,611,231 | 16,411 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $584,072 | 7,666 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||